Role of high-resolution ultrasonography in the evaluation of the tibial and median nerves in diabetic peripheral neuropathy
Open Access
- 1 October 2022
- journal article
- research article
- Published by Medical Communications Sp. z.o.o. in Journal of Ultrasonography
- Vol. 22 (91), 209-215
- https://doi.org/10.15557/jou.2022.0035
Abstract
Aim: To evaluate and measure the mean cross-sectional area of the tibial and median nerves in patients with diabetic peripheral neuropathy, and to study the association between high-resolution ultrasonographic findings in diabetic peripheral neuropathy with the duration of illness, glycosylated haemoglobin values, random blood sugar levels, and aesthesiometry (using monofilament examination). Material and methods: A prospective observational study was conducted among 63 patients who were diagnosed with type 2 diabetes mellitus and underwent ultrasound and monofilament examinations. The cross-sectional area of the median nerve of the dominant hand and the tibial nerves was calculated on ultrasound examination. Results: The mean cross-sectional area of the median and tibial nerves was higher in patients with poor glycaemic control, with the mean cross-sectional area of the median nerve being 10.9, 12.8, 13.0, and 12.9 mm(2) at various points in the leg in cases where the monofilament examination was negative, as compared to 7.30, 7.73, 7.91, 7.87 mm(2) in patients with positive monofilament examination results. There was a significant positive correlation between the cross-sectional area of the tibial and median nerves and HbA(1c), duration of diabetes, aesthesiometry, and random blood sugar levels. With an increase in HbA(1c), duration of diabetes, and random blood sugar levels, there was a corresponding increase in the cross-sectional area of the nerves. These findings helped us to identify diabetic peripheral neuropathy. Conclusions: High-resolution ultrasonography along with aesthesiometry and HbA(1c) values can be an effective and easily available tool for detecting changes secondary to diabetic peripheral neuropathy. The method has a potential to replace or substitute nerve conduction tests in the near future.Keywords
This publication has 22 references indexed in Scilit:
- Enhanced glucose control for preventing and treating diabetic neuropathyEmergencias, 2012
- Diabetic neuropathy: clinical manifestations and current treatmentsThe Lancet Neurology, 2012
- Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trialMuscle & Nerve, 2010
- Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trialThe Lancet, 2010
- Prediction of Incident Diabetic Neuropathy Using the Monofilament ExaminationDiabetes Care, 2010
- Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) StudyDiabetes Care, 2010
- The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathyJournal of Vascular Surgery, 2009
- THE DIABETIC NEUROPATHIES: TYPES, DIAGNOSIS AND MANAGEMENTJournal of Neurology, Neurosurgery & Psychiatry, 2003
- The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohortNeurology, 1993
- The neuropathies associated with diabetes mellitusNeurology, 1961